Data gathered: June 21
Alternative Data for ATAI Life Sciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 4,000 | Sign up | Sign up | Sign up |
| Employee Rating | 94 | Sign up | Sign up | Sign up |
| Google Trends | 21 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Instagram Followers | 145,562 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 64 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 4,276 | Sign up | Sign up | Sign up |
| Twitter Followers | 12,646 | Sign up | Sign up | Sign up |
| Twitter Mentions | 45 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 93 | Sign up | Sign up | Sign up |
| Linkedin Employees | 77 | Sign up | Sign up | Sign up |
About ATAI Life Sciences
atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, with offices in New York, San Diego and Berlin.
| Price | $2.48 |
| Target Price | Sign up |
| Volume | 3,940,000 |
| Market Cap | $491M |
| Year Range | $1.06 - $2.55 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of ShareholdersJune 15 - GlobeNewswire |
|
HAPPY FATHER’S DAY! and $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Atai Life Sciences N.V. (NASDAQ: ATAI)June 15 - GlobeNewswire |
|
ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to ShareholdersJune 3 - Finnhub |
|
 |
Biotech's ATAI Life Sciences Joins Roster of Firms With Bitcoin Treasury StrategiesMarch 20 - CoinDesk |
 |
Who Will Own the ‘God Molecule’?June 19 - New York Magazine |
 |
Trump Trade: President said to weigh possible U.S. strike against IranJune 19 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 1.6M | 0 | 1.6M | -26M | -25M | -0.150 |
| Q4 '24 | -5,000 | 170,000 | -150,000 | -39M | -38M | -0.240 |
| Q3 '24 | 40,000 | 0 | 40,000 | -26M | -26M | -0.160 |
| Q2 '24 | 270,000 | 82,000 | 190,000 | -57M | -57M | -0.360 |
| Q1 '24 | 0 | 83,000 | -83,000 | -27M | -25M | -0.170 |
Insider Transactions View All
| Apeiron Investment Group Ltd. filed to buy 42,369,415 shares at $1.4. March 24 '25 |
| Short Glenn Frank filed to sell 42,333 shares at $1.4. March 24 '25 |
| Johnson Anne Nagengast filed to sell 140,045 shares at $1.4. March 24 '25 |
| Rao Srinivas filed to sell 212,942 shares at $1.4. March 24 '25 |
| Craig Kevin James filed to sell 8,437 shares at $1.4. March 24 '25 |
Similar companies
Read more about ATAI Life Sciences (ATAI) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of ATAI Life Sciences?
The Market Cap of ATAI Life Sciences is $491M.
What is the current stock price of ATAI Life Sciences?
Currently, the price of one share of ATAI Life Sciences stock is $2.48.
How can I analyze the ATAI stock price chart for investment decisions?
The ATAI stock price chart above provides a comprehensive visual representation of ATAI Life Sciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling ATAI Life Sciences shares. Our platform offers an up-to-date ATAI stock price chart, along with technical data analysis and alternative data insights.
Does ATAI offer dividends to its shareholders?
As of our latest update, ATAI Life Sciences (ATAI) does not offer dividends to its shareholders. Investors interested in ATAI Life Sciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of ATAI Life Sciences?
Some of the similar stocks of ATAI Life Sciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.